4Vote!
Nature Publishing Group (Free subscription) | yesterday
New methods of cardiac troponin measurement accurately characterize patients as they present to the emergency department. Decisions on admission or discharge within 1–2 h of initial assessment (rather than 6–12 h thereafter), therefore, have become feasible. This development has potential for a major influence on how patients with chest pain are managed.
4Vote!
Nature Publishing Group (Free subscription) | yesterday
Endoscopic harvesting of saphenous veins for use in CABG surgery has become standard practice worldwide. This strategy reduces postoperative infection and hospital stay, and increases patients' satisfaction when compared with open harvest. However, long-term follow-up data provided by Lopes et al. indicate that widespread use of this technique must be urgently reviewed.
4Vote!
Nature Publishing Group (Free subscription) | yesterday
The novel antiplatelet agent ticagrelor was evaluated against clopidogrel in the PLATO trial of patients with acute coronary syndromes. This article discusses the main findings and importance of this study, including the reduction in mortality associated with ticagrelor therapy.
4Vote!
Nature Publishing Group (Free subscription) | yesterday
During the course of 2009 the Nature Reviews Cardiology editorial team were shocked and saddened to learn of the deaths of two of our esteemed advisory board members, Philip Poole-Wilson and Helmut Drexler. In addition to interactions with them in their roles on the
4Vote!
Nature Publishing Group (Free subscription) | yesterday
Interventional cardiology: A bright future for biodegradable polymer DESs? Nature Reviews Cardiology 6, 736 (2009). doi:10.1038/nrcardio.2009.182 Author: Alexandra King
4Vote!
Nature Publishing Group (Free subscription) | yesterday
Predicting response to CRT in patients with HF Nature Reviews Cardiology 6, 735 (2009). doi:10.1038/nrcardio.2009.183 Author: Bryony M. Mearns
4Vote!
Nature Publishing Group (Free subscription) | yesterday
Public health: Pollution and cardiovascular risk Nature Reviews Cardiology 6, 734 (2009). doi:10.1038/nrcardio.2009.195 Author: Sharmini Rajanayagam
4Vote!
Nature Publishing Group (Free subscription) | yesterday
Vascular disease: Metabolic syndrome increases risk of peripheral artery disease in women Nature Reviews Cardiology 6, 734 (2009). doi:10.1038/nrcardio.2009.194 Author: Alexandra King
+Vote!
Nature Publishing Group (Free subscription) | yesterday
Low-dose β-blocker for POTS Nature Reviews Cardiology 6, 733 (2009). doi:10.1038/nrcardio.2009.181 Author: Bryony M. Mearns
+Vote!
Nature Publishing Group (Free subscription) | yesterday
Hypertension: Low-salt diet vital for patients with resistant hypertension Nature Reviews Cardiology 6, 733 (2009). doi:10.1038/nrcardio.2009.179 Author: Alexandra King
+Vote!
Nature Publishing Group (Free subscription) | yesterday
Interventional cardiology: Clinical benefits of thrombectomy Nature Reviews Cardiology 6, 733 (2009). doi:10.1038/nrcardio.2009.177 Author: Sharmini Rajanayagam
+Vote!
Nature Publishing Group (Free subscription) | yesterday
Statins reduce the occurrence of AF Nature Reviews Cardiology 6, 732 (2009). doi:10.1038/nrcardio.2009.180 Author: Sharmini Rajanayagam
+Vote!
Nature Publishing Group (Free subscription) | yesterday
Acute coronary syndromes: Bivalirudin improves 1-year survival in patients with STEMI undergoing PCI Nature Reviews Cardiology 6, 732 (2009). doi:10.1038/nrcardio.2009.178 Author: Alexandra King
+Vote!
Nature Publishing Group (Free subscription) | yesterday
Acute coronary syndromes: A new factor Xa inhibitor for acute coronary syndrome Nature Reviews Cardiology 6, 731 (2009). doi:10.1038/nrcardio.2009.176 Author: Sharmini Rajanayagam
+Vote!
Nature Publishing Group (Free subscription) | yesterday
Hypertension is a huge global health concern. In 2002, the WHO reported that this condition was the cause of 7.1 million deaths (13% of the total) and represented 4.5% of the disease burden worldwide. Crucially, elevated blood pressure was the risk factor associated with the
3Vote!
bsalmons | 29/07/2009
The Centers for Disease Control and Prevention reported the costs of treating obesity were about $147 billion in 2008, while in 1998 they were about $74 billion. What does this mean? It means obese people tend to spend 42% more than fit people on medical costs; at least these were the facts in 2006. Thomas Frieden is the CDC’s new director and he says an average American is almost 23 pounds overweight
Click here to see all comments
it hurts
I don't know if this hurts because it's true or because it makes me realize I have to do something about it.
deboramcna - 29/07/2009